The ClinGen Evidence Repository is an FDA-recognized human genetic variant database containing expert-curated assertions regarding variants' pathogenicity and supporting evidence summaries. [Disclaimer]


Variant: NM_000051.4(ATM):c.217_218del (p.Glu73fs)

CA6264537

569567 (ClinVar)

Gene: ATM
Condition: hereditary breast cancer
Inheritance Mode: Autosomal dominant inheritance
UUID: 673ac80a-e147-4045-9c13-2d6372ba5558
Approved on: 2024-01-25
Published on: 2024-02-14

HGVS expressions

NM_000051.4:c.217_218del
NM_000051.4(ATM):c.217_218del (p.Glu73fs)
NC_000011.10:g.108229209_108229210del
CM000673.2:g.108229209_108229210del
NC_000011.9:g.108099936_108099937del
CM000673.1:g.108099936_108099937del
NC_000011.8:g.107605146_107605147del
NG_009830.1:g.11378_11379del
ENST00000452508.7:c.217_218del
ENST00000683914.2:c.217_218del
ENST00000713593.1:c.217_218del
ENST00000278616.9:c.217_218del
ENST00000682147.1:n.347_348del
ENST00000682430.1:n.316_317del
ENST00000682465.1:c.217_218del
ENST00000682516.1:n.351_352del
ENST00000682956.1:n.351_352del
ENST00000683150.1:c.217_218del
ENST00000683174.1:n.367_368del
ENST00000683468.1:c.217_218del
ENST00000683488.1:n.4877_4878del
ENST00000683914.1:c.217_218del
ENST00000684029.1:c.217_218del
ENST00000684037.1:c.217_218del
ENST00000684061.1:n.351_352del
ENST00000684179.1:n.351_352del
ENST00000527805.6:c.217_218del
ENST00000638443.1:c.217_218del
ENST00000639240.1:c.217_218del
ENST00000639953.1:c.217_218del
ENST00000640388.1:c.217_218del
ENST00000675595.1:c.217_218del
ENST00000675843.1:c.217_218del
ENST00000278616.8:c.217_218del
ENST00000452508.6:c.217_218del
ENST00000526567.5:c.217_218del
ENST00000527805.5:c.217_218del
ENST00000527891.5:c.217_218del
ENST00000530958.5:c.217_218del
ENST00000532931.5:c.217_218del
ENST00000601453.2:c.217_218del
NM_000051.3:c.217_218del
NM_001351834.1:c.217_218del
NM_001351835.1:c.217_218del
NM_001351836.1:c.217_218del
NM_001351834.2:c.217_218del
NM_001351835.2:c.217_218del
NM_001351836.2:c.217_218del

Pathogenic

Met criteria codes 4
PM2_Supporting PVS1 PM5_Supporting PM3_Very Strong

Evidence Links 0

Expert Panel

Criteria Specification Information

Criteria Specification: ClinGen Hereditary Breast, Ovarian and Pancreatic Cancer Expert Panel Specifications to the ACMG/AMP Variant Interpretation Guidelines for ATM Version 1.1

Criteria Specification Approval History
Criteria Specifications for this VCEP
Evidence submitted by expert panel
Hereditary Breast, Ovarian and Pancreatic Cancer VCEP
The c.217_218del (p.Glu73Metfs*26) variant in ATM is a frameshift variant in a biologically-relevant-exon predicted to cause a premature stop codon leading to nonsense mediated decay in a gene in which loss-of-function is an established disease mechanism. This alteration results in a termination codon upstream of the most C-terminus pathogenic alteration (ATM p.Arg3047*), as classified by the HBOP VCEP, and is expected to be more deleterious. This variant has been detected in at least 5 individuals with Ataxia-Telangiectasia (PMIDs 26677768; 26896183; 22649200; 10817650). This variant is absent from gnomAD v2.1. In summary, this variant meets criteria to be classified as pathogenic for autosomal dominant hereditary breast cancer and autosomal recessive Ataxia-Telangiectasia based on the ACMG/AMP criteria applied, as specified by the HBOP VCEP. (PVS1, PM5_Supporting, PM3_VeryStrong, PM2_Supporting)
Met criteria codes
PM2_Supporting
This variant is absent from gnomAD v2.1 (PM2_Supporting).
PVS1
The c.217_218del p.Glu73Metfs*26 variant in ATM is a frameshift variant in biologically-relevant-exon predicted to cause a premature stop codon leading to nonsense mediated decay in a gene in which loss-of-function is an established disease mechanism.
PM5_Supporting
This alteration results in a termination codon upstream of the most C-terminus pathogenic alteration (ATM p.Arg3047*), as classified by the HBOP VCEP, and is expected to be more deleterious.
PM3_Very Strong
This variant has been observed in at least four homozygous and compound heterozygous (confirmed and presumed) in multiple individuals with Ataxia-Telangiectasia (PMIDS 26677768; 26896183; 22649200; 10817650: 8 POINTS-PM3_VeryStrong).
The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. If you have questions about the information contained on this website, please see a health care professional.
¤ Powered by BCM's Genboree.